408 Matching Annotations
  1. Last 7 days
    1. IMPACT4HC. (2021, June 10). FACT: Asking about vaccine status does NOT violate HIPAA. ¡También en #Español! Submit questions to impact4hc@gmail.com. #VaxUpIL #ThisIsOurShot #igottheshot #HIPAA https://t.co/zbjwMTb9Gp [Tweet]. @IMPACT4HC. https://twitter.com/IMPACT4HC/status/1403000380699516931

    1. Mocking is a form of global state like others (including ENV sharing), which will cause difficulties here (more with threads, a bit less with forks).
  2. Jun 2021
    1. Wall, E. C., Wu, M., Harvey, R., Kelly, G., Warchal, S., Sawyer, C., Daniels, R., Hobson, P., Hatipoglu, E., Ngai, Y., Hussain, S., Nicod, J., Goldstone, R., Ambrose, K., Hindmarsh, S., Beale, R., Riddell, A., Gamblin, S., Howell, M., … Bauer, D. L. (2021). Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(21)01290-3

    1. Ryan Struyk. (2021, June 2). WHO Director General: ‘Of the 1.8 billion vaccines administered globally, just 0.4% have been administered in low-income countries. This is ethically, epidemiologically and economically unacceptable.’ [Tweet]. @ryanstruyk. https://twitter.com/ryanstruyk/status/1400114783882461190

  3. May 2021
    1. Prof. Azeem Majeed. (2021, May 20). 1/ Our new article in @bmj_latest discusses vaccine hesitancy and how health professionals can collaborate with patients to improve confidence in vaccines. WHO has identified vaccine hesitancy as one of the top threats to global health. Https://t.co/V9nwAKbm8Z @MohammadRazai [Tweet]. @Azeem_Majeed. https://twitter.com/Azeem_Majeed/status/1395356264390135820

    1. Jarrad Hall. (2021, May 9). There’s a lot of speculation that COVID may become less virulent. This is still an old concept in the field, akin to aerosol vs droplet. In my own field it was assumed that resistance came at the expense of virulence. [Tweet]. @CdrHBiscuitIII. https://twitter.com/CdrHBiscuitIII/status/1391265635749957632

    1. ReconfigBehSci. (2021, February 18). @ErikAngner I thought I joined the ‘conversation’ at the top- did I miss part of a prior thread? Post I responded to seemed to be the beginning of a thread...ie. ‘regular reminder that...’ [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1362385973603168257

    1. Dron, L., Taljaard, M., Cheung, Y. B., Grais, R., Ford, N., Thorlund, K., Jahan, F., Nakimuli-Mpungu, E., Xavier, D., Bhutta, Z. A., Park, J. J. H., & Mills, E. J. (2021). The role and challenges of cluster randomised trials for global health. The Lancet Global Health, 9(5), e701–e710. https://doi.org/10.1016/S2214-109X(20)30541-6

    1. The Lancet. (2021, April 16). Quantity > quality? The magnitude of #COVID19 research of questionable methodological quality reveals an urgent need to optimise clinical trial research—But how? A new @LancetGH Series discusses challenges and solutions. Read https://t.co/z4SluR3yuh 1/5 https://t.co/94RRVT0qhF [Tweet]. @TheLancet. https://twitter.com/TheLancet/status/1383027527233515520

    1. Health Nerd. (2021, March 28). Recently, Professor John Ioannidis, most famous for his meta-science and more recently COVID-19 work, published this article in the European Journal of Clinical Investigation It included, among other things, a lengthy personal attack on me Some thoughts 1/n https://t.co/JGfUrpJXh2 [Tweet]. @GidMK. https://twitter.com/GidMK/status/1376304539897237508

    1. Park, J. J. H., Grais, R. F., Taljaard, M., Nakimuli-Mpungu, E., Jehan, F., Nachega, J. B., Ford, N., Xavier, D., Kengne, A. P., Ashorn, P., Socias, M. E., Bhutta, Z. A., & Mills, E. J. (2021). Urgently seeking efficiency and sustainability of clinical trials in global health. The Lancet Global Health, 9(5), e681–e690. https://doi.org/10.1016/S2214-109X(20)30539-8

  4. Apr 2021
    1. Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., Drew, D. A., Nguyen, L. H., Polidori, L., Selvachandran, S., Hu, C., Capdevila, J., Koshy, C., Ash, A., Wise, E., … Ourselin, S. (2021). Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: An ecological study. The Lancet Public Health, 0(0). https://doi.org/10.1016/S2468-2667(21)00055-4